CVEO vs RARE · rev $352.7M vs rev $350.0M
Civeo Corp (CVEO) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Civeo Corp (CVEO) is a lodging company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported CVEO revenue for 2026-06-30 was $352.7M. Net income was -$6.3M. CVEO currently screens at market cap $309.8M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
CVEO currently screens at market cap $309.8M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the CVEO and RARE stock pages for the full models.
Not investment advice.